Article
The splicing factor SRSF6 regulates AR activity and represents a potential therapeutic target in prostate cancer
2023-05-08
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold> Prostate cancer (PCa) is the fifth leading cause of cancer-related death worldwide. Finding novel therapeutic strategies to tackle PCa, especially its most advanced phenotype, named castration-resistant PCa (CRPC), is urgently needed. In this sense, although the dysregulation of the splicing process has emerged as a distinctive feature of advanced PCa, the potent...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e3b7d1da-f2ab-5e68-814e-e1662821d4ad
- DOI
- 10.21203/rs.3.rs-2885147/v1
